Browse by Poster Presenter

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

L
Lacroix, Isabelle

CHU de Toulouse, INSERM 1295
(A21) Topical azole treatments during pregnancy: Are there risks for the pregnant mother and the fetus? A comparative study in the EFEMERIS database
Isabelle Lacroix
Favorite
Lai, Edward Chia-Cheng

Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
(B10) Comparison of common protocol vs. common data model and the issues of analytic inconsistency for a multi-database pharmacoepidemiologic study
Edward Chia-Cheng Lai
Favorite
(B12) Effect of Bisphosphonates versus Denosumab on Risks of Cardiovascular Events in Patients with Type 2 Diabetes
Edward Chia-Cheng Lai
Favorite
Lai, Francisco Tsz Tsun

University of Hong Kong
(202) BNT162b2 effectiveness after extending the primary-series dosing interval in children and adolescents
Francisco Tsz Tsun Lai
Favorite
Lai, Hsi-Yu

Health Data Research Center, National Taiwan University, Taipei, Taiwan.
(166) Clinical Outcomes and Treatment Pattern of Older Patients with Heart Failure Across Different Frailty Severity Status: a Nationwide Cohort Study of 38,843 Newly Hospitalized Heart Failure Patients
Hsi-Yu Lai
Favorite
Lambert, Maarten

University of Groningen
(285) Auditing Antibiotic Dispensing Practices in Community Pharmacies in 5 EU Countries
Maarten Lambert
Favorite
(288) Do’s and Don’ts for the European Community Pharmacist When Dispensing Antibiotics: A Delphi Study
Maarten Lambert
Favorite
Lane, Samantha

Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
(093) Rapid Production of Pharmacoepidemiology Results to Inform Regulatory Decision-making: Lessons Learned from the COVID-19 Pandemic
Samantha Lane
Favorite
(186) Appropriate Use of Observed Versus Expected Analyses for Newly Emerging Safety Concerns: The Case of Vaccine-Induced Thrombotic Thrombocytopenia Following COVID-19 Vaccination
Samantha Lane
Favorite
(231) Evidence Supporting Product Withdrawals for Safety Reasons in Europe: Shift of the Trend Over Time
Samantha Lane
Favorite
Laudano, Joseph

IQVIA
(224) Sub-Analyses, Post-Hoc Analyses and Full Publication Rate: Are we Potentially Missing Important Evidence?
Joseph Laudano
Favorite
Lauffenburger, Julie

BWH Div of Pharmacoepidemiology and Pharmacoeconomics
(049) Investigating the ability to adhere to cardiometabolic medication properties: a retrospective cohort study
Julie Lauffenburger
Favorite
Lavallee, Martin

Odysseus Data Services Inc.
(167) Heart failure burden in patients with incident CKD in the US: a multi-database FOUNTAIN analysis
Martin Lavallee
Favorite
(169) Treatment with antidiabetics in patients with T2D and moderate to severe CKD: a multi-database FOUNTAIN analysis
Martin Lavallee
Favorite
Lavigne, Jill

Wegmans School of Pharmacy, St John Fisher College
(207) Risk of Suicidal Behavior after Benztropine Initiation
Jill Lavigne
Favorite
(215) Vitamin D Serum Levels, Supplementation and Suicidal Behavior in Veterans
Jill Lavigne
Favorite
Lavu, Alekhya

The University of Manitoba
(104) Antiseizure medication use in pregnancy and adverse neonatal birth outcomes: a population-based cohort study
Alekhya Lavu
Favorite
(112) Gabapentin use during pregnancy and adverse neonatal birth outcomes: a population-based cohort study
Alekhya Lavu
Favorite
(144) Antiseizure medication safety in pregnant people for non-epilepsy conditions
Alekhya Lavu
Favorite
Layton, Deborah

PEPI Consultancy Limited
(C03) Contemporary pharmacoepidemiology practice for real world data source identification and feasibility assessment – Results from an ISPE-sponsored online survey
Deborah Layton
Favorite
Layton, J. Bradley

RTI Health Solutions
(298) Effectiveness of Monovalent COVID-19 Booster/Additional Vaccine Doses in the United States
J. Bradley Layton
Favorite
Leal, Lisiane

Research Centre - CHU Sainte-Justine
(107) The AMerican PREGNANcy-Mother-Child Cohort (AM-PREGNANT): Description and prevalence of main perinatal outcomes and medication use
Lisiane Leal
Favorite
Leclerc, Jacinthe

Universite Laval
(072) Association between Mortality and Cumulative Exposure to Antipsychotics, Antidepressants and Benzodiazepines in Patients with Schizophrenia: A Real-World Observational Study
Jacinthe Leclerc
Favorite
Lecomte, Coralie

Aetion, Inc.
(128) Identifying fit-for-purpose existing data sources for COVID-19 pre-exposure prophylaxis in pregnancy
Coralie Lecomte
Favorite
(139) Challenges and opportunities of European population-based data sources to support regulatory safety-related research questions in pregnancy
Coralie Lecomte
Favorite
(155) Replicating a US-claims cardiovascular use case in Japanese databases: opportunities and challenges
Coralie Lecomte
Favorite
(C04) European Rare Disease Registries: A Collaborative Effort to Assess the Quality and Suitability of Registries to Describe the Natural History of Disease and Treatment Landscape of Spinal Muscular Atrophy
Coralie Lecomte
Favorite
Ledlie, Shaleesa

Leslie Dan Faculty of Pharmacy, University of Toronto
(002) Assessing The Impact of the Slow-Release Oral Morphine Drug Shortages in Ontario: a Population-Based Time Series Analysis
Shaleesa Ledlie
Favorite
(097) The Impact of the COVID-19 Pandemic on the Burden of Opioid Toxicity Deaths Across Canada
Shaleesa Ledlie
Favorite
Lee, Annika

Pfizer Inc.
(125) Validating birth proxy algorithms in Medicaid administrative claims
Annika Lee
Favorite
Lee, Hsin

Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
(051) Utilization of antidepressants in patients with chronic kidney disease: A nationwide cohort study
Hsin Lee
Favorite
Lee, Hui-Eon

Department of Industrial Pharmaceutical Science, College of Pharmacy, Ewha Womans University
(048) Effectiveness of 2-dose COVID-19 Vaccination Against SARS-CoV-2 Infection and Severe Outcomes in Cancer Patients
Hui-Eon Lee
Favorite
Lee, Hyesung

School of Pharmacy, Sungkyunkwan University, South Korea
(305) Risk of gestational outcomes and adverse events following immunization with influenza vaccine in pregnant women
Hyesung Lee
Favorite
Lee, Kyung Eun

College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
(174) Factors associated with diabetic cataract:a population-based nested case-control study in korea
Kyung Eun Lee
Favorite
Lee, Wan-Ju Annabelle

Department of Ophthalmology, Chi Mei Medical Center, Tainan
(043) Renal Adverse Events in Patients with Diabetic Macular Edema Receiving Intravitreal Vascular Endothelial Growth Factors Inhibitors
Wan-Ju Annabelle Lee
Favorite
Le, Hoa

Daiichi Sankyo
(245) Evaluation of Handling Degrees of Missingness in the Features of Machine Learning Algorithms to Predict Overall Survival Using Real-World Lung Cancer Data
Hoa Le
Favorite
Lei, Feitong

Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, United States
(198) Urban-Rural Differences in Mortality among Patients Receiving Buprenorphine for Opioid Use Disorder Treatment in Kentucky
Feitong Lei
Favorite
Lerro, Catherine

Oncology Center of Excellence, US Food and Drug Administration
(B39) Trends in New and Persistent Opioid Use in Older Adults with Cancer
Catherine Lerro
Favorite
Leung, Miriam

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.
(144) Hip fracture incidence and post-fracture mortality in Victoria, Australia from 2012 to 2018
Miriam Leung
Favorite
Levesque, Linda

Sanofi
(263) Post-Authorization Safety Study: Cohort Event Monitoring for CYD-TDV Dengue Vaccine (DNG15)
Linda Levesque
Favorite
Levy, Adrian

Dalhousie University
(007) Prescription Ranitidine Use and Population Exposure in Six Canadian Provinces, 1996 to 2019
Adrian Levy
Favorite
Liang, David

Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
(221) Methods in Dynamic Treatment Regimens using Observational Data: A Systematic Review
David Liang
Favorite
Liang, Huifang

AbbVie
(207) Clinical Characteristics of Patients with Different Types of Psoriasis In Optum Market Clarity Data
Huifang Liang
Favorite
Li, Brian

School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
(B11) Comparisons of non-vitamin K antagonist oral anticoagulants and warfarin for incident depressive disorders in patients with atrial fibrillation: A nationwide cohort study using target trial emulation framework
Brian Li
Favorite
Li, Can

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University
(C49) Potential inappropriate medication use among older patients with Parkinson’s disease: A cross sectional analysis of a national health insurance database in China
Can Li
Favorite
Liede, Alexander

AbbVie
(C13) Machine learning (ML) model for prediction of pneumonitis using real-world data (RWD) on immune checkpoint inhibitor (ICI)-treated advanced non-small cell lung cancer (aNSCLC)
Alexander Liede
Favorite
Li, Hu

Gilead Science Inc.
(019) Real World Evidence (RWE) Couture: attributes of well-fitting regulatory grade evidence for efficacy decision making
Hu Li
Favorite
Li, Huiqi

School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
(092) Ursodeoxycholic acid may be a new protective factor for severe COVID-19 outcomes – evidence from a nationwide Swedish register-based cohort study within the SCIFI-PEARL project
Huiqi Li
Favorite
Li, Jie

US Food and Drug Administration
(214) A Systematic Literature Review of Current Application of Machine Learning for Patient Phenotyping and Selection in Observational Studies
Jie Li
Favorite
(A42) Case studies of FDA recently approved product applications using real-world evidence - What are the attributes of studies that support effectiveness determinations?
Jie Li
Favorite
Li, Ling

Kite
(087) Risk Prediction of Long COVID with Machine Learning in a Real-World Setting
Ling Li
Favorite
Li, Mengying

IQVIA
(164) Real-world studies evaluating patients with HER2-low breast cancer: A systematic review and meta-analysis
Mengying Li
Favorite
Limoncella, Giorgio

University of Florence, Florence, Italy
(225) A statistical test for differential sensitivity of study outcome
Giorgio Limoncella
Favorite
Lin, Jialing

School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
(126) Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)
Jialing Lin
Favorite
Liu, Shania

The University of Sydney
(134) Predictors of Opioid Use Before and After Orthopaedic Surgery in an Australian Setting: A Multicentre, Cross-Sectional, Observational Study
Shania Liu
Favorite
Liu, Xiaodong

The University of Hong Kong
(219) Discharging postoperative patients with an opioid prescription may result in greater reliance on opioid itself and increased healthcare expenditure and mortality
Xiaodong Liu
Favorite
Liu, Xinyue

Merck & Co. Inc.
(001) Exploratory Analysis of Patient Characteristics and Treatment Duration in Patients using Esketamine for Treatment-Resistant Depression: A Large Longitudinal Study Linking Commercial Claims Data to Electronic Medical Records
Xinyue Liu
Favorite
Liu, Yi-Shao

The University of Texas at Austin
(227) Risk of Cardiovascular Events with Cyclin-Dependent Kinases 4 and 6 (CDK 4/6) Inhibitors among Patients with Metastatic Breast Cancer: A Systematic Review and Network Meta-Analysis
Yi-Shao Liu
Favorite
Li, Xiaotong

University of Pittsburgh
(018) Interaction Between Cannabis And Cytochromes P450 Substrates: Potential Safety Signals from a Disproportionality Analysis Using the US Food And Drug Administration Adverse Event Reporting System Database
Xiaotong Li
Favorite
Li, Xintong

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
(231) Bespoke Code vs. Off-the-shelf R Package in Calculating Incidence Rates Using Real-World Data
Xintong Li
Favorite
(C01) Agreement of COVID-19 Incidence Between the Authoritative Data and Real-World Evidence in England
Xintong Li
Favorite
Li, Yan

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
(A32) Utilization of beta-blockers among the pediatric population in the United States: a study in the FDA’s Sentinel System from 2008 to 2022
Yan Li
Favorite
Li, Yujia

Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy
(205) Effects of sodium-glucose cotransporter 2 inhibitors on the risk of atrial fibrillation in older adults with type 2 diabetes
Yujia Li
Favorite
Lopez Leon, Sandra

Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, United States of America
(101) Drug utilisation studies in pregnant women for newly licensed medicinal products: reflections from IMI-ConcePTION
Sandra Lopez Leon
Favorite
(146) Prevalence of multiple sclerosis in women of childbearing age potential in Europe: A contribution from IMI ConCEPTION
Sandra Lopez Leon
Favorite
(C20) Patient characteristics and treatment patterns for migraine patients initiating erenumab in Denmark and Sweden
Sandra Lopez Leon
Favorite
Lukusa, Luck

Research Institute of the McGill University Health Centre
(068) Safety & immUnogenicity of COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED): Preliminary Results of 1031 Patients
Luck Lukusa
Favorite
Lund, Jennifer

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
(C52) Validating Medicare claims-based algorithms for deprescribing of benzodiazepines using a novel linkage with electronic health records data
Jennifer Lund
Favorite
Lu, Yun

US Food and Drug Administration
(121) Characterization of Long COVID among U.S. Medicare Beneficiaries using Claims Data
Yun Lu
Favorite
Ly, Nelly

IQVIA UK Ltd
(081) An Analysis Of The Impact Of The COVID-19 Pandemic Outbreak On Incident Patient Diagnoses In Primary Care In England Using An Interrupted Time Series
Nelly Ly
Favorite
Lysen, Thom

IQVIA Solutions B.V.
(045) Impact of European Union label changes to avoid inadvertent use of once-weekly methotrexate: A cross-sectional survey amongst prescribers, pharmacists and patients on awareness, knowledge, and behaviour
Thom Lysen
Favorite